EUVIMEDEUVIMED entdecken
ValidierungsstudieSystematische ÜbersichtDelphi-StudieOpen Access · CC BY-NC-ND 4.0

Content Validation of a Medication Adherence Risk Score ( MARS ) for Mortality Risk Prediction: A Delphi Consensus

Jessica Hamuy Blanco iD, Dina C Janse van Rensburg iD, Audrey Jansen van Rensburg iD, Natalie Schellack iD

Clinical Pharmacology & Therapeutics · 2026

DOI: 10.1002/cpt.70274 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Jessica Hamuy Blanco und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Hauptthemen laut MEDLINE: Medication Adherence, Mortality. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Medication Adherence Risk Score (MARS) is an objective adherence‐based score, derived from transactional dispensary data. This study provides expert consensus to validate the use of the MARS as a predictor of mortality risk. A systematic review and assessment of South African health legislation and professional guidelines informed the development of consensus statements regarding the relevance, validity, predictive power, and implementation feasibility of the MARS. A two‐round modified Delphi approach using a 5‐point Likert scale was employed. Consensus was reached if at least 80% of respondents selected “agree” or “strongly agree.” Nonconsensus statements were revised based on qualitative feedback and subsequently reevaluated in a second round. Thirteen clinical, actuarial, and academic experts were successfully recruited. Consensus was achieved for 20 of the 28 statements in Round 1. Five of 18 (27.8%; risk score components), 1 of 3 (33.3%, validity/predictive power), and 2 of 7 statements (26.5%, real‐world implementation) did not initially reach consensus. Nonconsensus statements were revised to provide clarity, after which consensus was achieved for all statements by the end of Round 2. Expert consensus supports the inclusion, exclusion, and weighting of MARS risk factors. The panel agreed that the score offers predictive value for mortality outcomes, and that real‐world application for enhancing risk stratification and reducing healthcare costs is feasible. Future statistical analysis is necessary to demonstrate its relationship with mortality risk. Developing practical implementation strategies will facilitate incorporation into clinical practice and public health interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medication AdherenceMortalityHumansDelphi TechniqueRisk AssessmentConsensusSouth AfricaRisk FactorsPredictive Value of TestsReproducibility of Results

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Section Sports Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

ORCID-Profile: Jessica Hamuy Blanco, Dina C Janse van Rensburg, Audrey Jansen van Rensburg, Natalie Schellack

Zitieren

APA

Hamuy Blanco, J., Janse van Rensburg, D. C., van Rensburg, A. J., & Schellack, N. (2026). Content Validation of a Medication Adherence Risk Score ( MARS ) for Mortality Risk Prediction: A Delphi Consensus. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70274

Vancouver

Hamuy Blanco J, Janse van Rensburg DC, van Rensburg AJ, Schellack N. Content Validation of a Medication Adherence Risk Score ( MARS ) for Mortality Risk Prediction: A Delphi Consensus. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70274

BibTeX
@article{HamuyBlanco2026,
  author = {Hamuy Blanco, Jessica and Janse van Rensburg, Dina C and van Rensburg, Audrey Jansen and Schellack, Natalie},
  title = {Content Validation of a Medication Adherence Risk Score ( MARS ) for Mortality Risk Prediction: A Delphi Consensus},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70274}
}
Kostenlos starten →